InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Murray Dallan. Director active across 1 company, notably Sarepta Therapeutics, Inc.. Cumulatively, 6 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €474k. Activity tracked since 2 May 2024. The latest transaction was disclosed on 4 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Murray Dallan is a declarant linked to Sarepta Therapeutics, Inc. (XNAS), where the listed role is Chief Customer Officer. Across 6 filings in total, the 6 sampled filings cover the period from 2024-05-06 to 2025-03-11, with EUR 0 of buys and EUR 474142 of sells; the modal transaction nature is Levée d'options.